Biotech

All Articles

Galapagos stops briefly CAR-T cell therapy litigation over Parkinsonism situation

.Galapagos has stopped enrollment in a trial of a BCMA-directed CAR-T tissue treatment, pumping the ...

James Wilson leaving behind Penn to introduce 2 brand-new biotechs

.After greater than three decades, gene therapy trendsetter James Wilson M.D., Ph.D., is leaving beh...

3 biotechs try to trump the summer months heat by dropping staff

.As biotechs attempt to turn a fresh webpage in August, at least three providers have shed personnel...

venBio elevates $528M for fifth life sciences VC fund

.Pro financial backing agency venBio has actually lifted one more half a billion bucks to invest in ...

Otsuka pays out $800M for Jnana as well as its clinical-stage PKU medicine

.Otsuka Drug has actually gotten Boston-based Jnana Therapies for $800 million so the Oriental biote...

FibroGen lays off 75% of US team as resource flunks 2 more tests

.FibroGen is actually significantly restructuring its own organization, giving up 75% of its USA sta...

Tracon winds down weeks after injectable PD-L1 inhibitor fall short

.Tracon Pharmaceuticals has decided to unwind functions weeks after an injectable immune gate inhibi...

Ideaya bags possibility on Biocytogen bispecific ADC in $400M deal

.Ideaya Biosciences is actually wagering $400 million in biobucks that a bispecific antibody-drug co...

Takeda takes $140M loss on failed epilepsy drug, boasts FDA manage

.Our experts currently understand that Takeda is actually hoping to find a course to the FDA for epi...

VBI Injections declare personal bankruptcy, seeks asset purchase

.Immunology biotech VBI Injections is actually veering precariously close to the defining moment, al...